🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

pharmanewsdaily

1509 posts
Read More

US pharma manufacturer Conagen acquires glycoproteins production platform

US pharma manufacturer Conagen has purchased a glycoproteins production platform – a fermentation-based technology for the production of glycoproteins used for making therapeutics, for an undisclosed price. The acquisition made from an undisclosed seller includes various patents covering the glycoproteins production platform and all related tangible assets, which are expected to place Conagen among the […]

The post US pharma manufacturer Conagen acquires glycoproteins production platform appeared first on PharmaNewsDaily.com.

Read More

Eiger bags FDA breakthrough therapy status for HDV drug candidate Lambda

US biopharma company Eiger BioPharmaceuticals said that peginterferon lambda (Lambda) has been granted breakthrough therapy designation from the US Food and Drug Administration (FDA) for the treatment of hepatitis delta virus (HDV) infection. Breakthrough therapy designation enables expedition of the development and review of drugs intended for the treatment of a serious condition and where […]

The post Eiger bags FDA breakthrough therapy status for HDV drug candidate Lambda appeared first on PharmaNewsDaily.com.

Read More

NKMax America launches SNK01-MX03 clinical trial in plaque psoriasis

SNK01-MX03 clinical trial : NKMax America, a US biotech company, has initiated a phase 1 trial called SNK01-MX03 to investigate its ex vivo expanded autologous natural killer cell therapeutic SNK in plaque psoriasis. In this connection, NKMax America treated the first patient in the SNK01-MX03 clinical trial, which is a single center, dose-escalation study for […]

The post NKMax America launches SNK01-MX03 clinical trial in plaque psoriasis appeared first on PharmaNewsDaily.com.